Federated Hermes Portfolio holdings
AUM
$53.1B
1-Year Return
30.23%
This Quarter Return
-16.34%
1 Year Return
+30.23%
3 Year Return
+93.51%
5 Year Return
+187.87%
10 Year Return
+487.63%
AUM
$33.7B
AUM Growth
-$11B
(-25%)
Cap. Flow
-$1.48B
Cap. Flow
% of AUM
-4.39%
Top 10 Holdings %
Top 10 Hldgs %
18.78%
Holding
2,451
New
252
Increased
885
Reduced
1,005
Closed
224
Top Buys
| 1 |
Merck
MRK
|
$199M |
| 2 |
Moderna
MRNA
|
$140M |
| 3 |
United Parcel Service
UPS
|
$133M |
| 4 |
Gilead Sciences
GILD
|
$114M |
| 5 |
Cisco
CSCO
|
$104M |
Top Sells
| 1 |
Ambarella
AMBA
|
$270M |
| 2 |
Ventas
VTR
|
$186M |
| 3 |
LyondellBasell Industries
LYB
|
$165M |
| 4 |
Amcor
AMCR
|
$161M |
| 5 |
Air Lease Corp
AL
|
$102M |
Sector Composition
| 1 | Healthcare | 22.59% |
| 2 | Technology | 16.3% |
| 3 | Consumer Discretionary | 10.14% |
| 4 | Financials | 10.04% |
| 5 | Communication Services | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Portland General Electric
POR
$4.69B
| $24.1M | 0.07% |
502,938
+80,800
| +19% | +$3.87M |
|
302
Martin Marietta Materials
MLM
$37.5B
| $24M | 0.07% |
126,824
-22,309
| -15% | -$4.22M |
|
303
Tetra Tech
TTEK
$9.48B
| $23.8M | 0.07% |
1,686,785
+214,570
| +15% | +$3.03M |
|
|
MDLA
304
DELISTED
Medallia, Inc.
MDLA
| $23.7M | 0.07% |
1,181,332
+329,269
| +39% | +$6.6M |
|
305
TransUnion
TRU
$17.5B
| $23.4M | 0.07% |
353,117
+18,454
| +6% | +$1.22M |
|
306
Target
TGT
$42.3B
| $23.4M | 0.07% |
251,258
-164,748
| -40% | -$15.3M |
|
307
RTX Corp
RTX
$211B
| $23.3M | 0.07% |
393,018
-110,423
| -22% | -$6.56M |
|
308
Hologic
HOLX
$14.8B
| $23.3M | 0.07% |
664,272
+385,672
| +138% | +$13.5M |
|
309
White Mountains Insurance
WTM
$4.63B
| $23.1M | 0.07% |
25,429
-1,223
| -5% | -$1.11M |
|
310
SEI Investments
SEIC
$10.8B
| $23.1M | 0.07% |
498,668
-26,041
| -5% | -$1.21M |
|
311
CACI
CACI
$10.4B
| $22.9M | 0.07% |
108,333
-34,889
| -24% | -$7.37M |
|
312
Openlane
KAR
$3.09B
| $22.9M | 0.07% |
1,904,447
+1,048,987
| +123% | +$12.6M |
|
|
TBIO
313
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $22.8M | 0.07% |
2,289,162
+192,634
| +9% | +$1.92M |
|
314
Axalta
AXTA
$6.89B
| $22.7M | 0.07% |
1,313,421
+27,745
| +2% | +$479K |
|
315
Exelon
EXC
$43.9B
| $22.6M | 0.07% |
862,296
-109,680
| -11% | -$2.88M |
|
316
Genmab
GMAB
$16.9B
| $22.5M | 0.07% |
1,063,747
-71,694
| -6% | -$1.52M |
|
317
Artisan Partners
APAM
$3.26B
| $22.5M | 0.07% |
1,048,091
+1,045,869
| +47,069% | +$22.5M |
|
318
Merus
MRUS
$5.1B
| $21.9M | 0.06% |
1,812,000
+734,605
| +68% | +$8.89M |
|
319
Gartner
IT
$18.6B
| $21.4M | 0.06% |
214,761
-10,538
| -5% | -$1.05M |
|
|
KRTX
320
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $21.3M | 0.06% |
296,411
+296,409
| +14,820,450% | +$21.3M |
|
321
Schlumberger
SLB
$53.4B
| $21.3M | 0.06% |
1,576,230
+1,227,055
| +351% | +$16.6M |
|
322
Medpace
MEDP
$13.7B
| $21.2M | 0.06% |
288,714
-225,477
| -44% | -$16.5M |
|
323
Glaukos
GKOS
$5.39B
| $21.1M | 0.06% |
683,470
| – | – |
|
|
PRAH
324
DELISTED
PRA Health Sciences, Inc.
PRAH
| $20.9M | 0.06% |
251,596
+131,146
| +109% | +$10.9M |
|
325
UGI
UGI
$7.43B
| $20.8M | 0.06% |
781,140
-91,937
| -11% | -$2.45M |
|